27394211000001102: Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\UK product\Virtual medicinal product\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\UK product\Virtual therapeutic moiety\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\UK product\Trade family\Triumeq\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing nucleotidyltransferase inhibitor\Product containing integrase strand transfer inhibitor\Product containing dolutegravir\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing reverse transcriptase inhibitor\Product containing abacavir\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing reverse transcriptase inhibitor\Product containing lamivudine\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing reverse transcriptase inhibitor\Product containing lamivudine\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrimidine\Product containing lamivudine\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrimidine\Product containing lamivudine\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing dolutegravir\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nucleoside analog\Product containing abacavir\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nucleoside analog\Product containing lamivudine\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nucleoside analog\Product containing lamivudine\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing dolutegravir\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing abacavir\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing lamivudine\Product containing dolutegravir and lamivudine (medicinal product)\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing lamivudine\Product containing abacavir and lamivudine\Product containing abacavir and dolutegravir and lamivudine\Abacavir + Lamivudine + Dolutegravir\Generic Triumeq 50mg/600mg/300mg tablets\Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Oct 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

83791601000001115 Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

83791701000001113 Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Is a	Generic Triumeq 50mg/600mg/300mg tablets	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	VMP prescribing status (attribute)	Never valid to prescribe as a VMP	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has specific active ingredient	Lamivudine	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has specific active ingredient	Dolutegravir sodium	false	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has specific active ingredient	Abacavir sulfate	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Dolutegravir	false	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Abacavir	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Is a	Triumeq	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has active ingredient	Substance with antiviral mechanism of action	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has active ingredient	Lamivudine	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has active ingredient	Abacavir	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Dolutegravir	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has specific active ingredient	Dolutegravir sodium	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has basis of strength substance	Abacavir	true	Inferred relationship	Existential restriction modifier
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Has basis of strength substance	Dolutegravir	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd) 30 tablet	Has AMP	True	Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
83791601000001115	Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
83791701000001113	Triumeq 50mg/600mg/300mg tablets (ViiV Healthcare UK Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module